Journals / Turkish Journal of Endocrinology and Metabolism / 2016 / Cilt: 20 - Sayı: 3

Büyüme Hormonu Salgılayan Adenomlarda İmmünohistokimyasal İnceleme Sonuçları ile Laboratuvar Bulguları Arasındaki Korelasyon

Immunostaining Results of Growth Hormone Secreting Adenomas and Their Correlation with Laboratory Findings

Pages
69–71
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Our data suggest that immunohistochemical results may not be correlated with the signs of hormone hypersecretion as evident by symptoms or laboratory results in patients with acromegaly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Depending on improvements in immunohistochemical and ultrastructural analyses, hormonal immunoreactivity are more commonly detected in pituitary adenomas.
📊
Key Findings & Data:In this study, we investigated the correlation between immunohistochemical results and clinical and laboratory findings.Material and Method: The records of 110 patients with acromegaly who were operated at our hospital were retrospectively evaluated.
💡
Conclusion & Impact:Discussion: Our data suggest that immunohistochemical results may not be correlated with the signs of hormone hypersecretion as evident by symptoms or laboratory results in patients with acromegaly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Depending on improvements in immunohistochemical and ultrastructural analyses, hormonal immunoreactivity are more commonly detected in pituitary adenomas. In this study, we investigated the correlation between immunohistochemical results and clinical and laboratory findings.Material and Method: The records of 110 patients with acromegaly who were operated at our hospital were retrospectively evaluated. Of the patients, 43 were excluded because of missing data. All patients were clinically evaluated preoperatively and had pituitary hormone profile. Results: Our study population was consisted of 42 females and 25 males. While there were 30 patients with growth hormone staining alone, plurihormonal staining was determined at the remaining 37 patients. Three of 14 patients were diagnosed with thyrotropin-secreting pituitary adenoma according to clinical and findings laboratory, preoperatively. Except these cases, there were no hormone-secreting adenomas even if positive cellular immunreactivity existed. Discussion: Our data suggest that immunohistochemical results may not be correlated with the signs of hormone hypersecretion as evident by symptoms or laboratory results in patients with acromegaly.

Özet

Amaç: Hipofiz adenomlarının sınıflamasında daha sensitif immünohistokimyasal ve ultrastrüktürel tekniklerin kullanılması ile hormon immünreaktivite gösteren adenomların insidansında artış olduğu belirtilmektedir. Bu çalışmada akromegali nedeniyle opere edilen hastaların immünohistokimyasal inceleme sonuçları ile klinik ve laboratuvar bulguları arasındaki ilişkiyi araştırdık.Gereç ve Yöntem: Hastanemizde akromegali nedeni ile opere edilen 110 hastanın verileri geriye dönük olarak tarandı. Kırk üç hastanın tetkikleri eksik olduğundan çalışma dışı bırakıldı. Tüm hastalar klinik ve laboratuvar olarak operasyon öncesi değerlendirilmiştir. Bulgular: Hastaların 42'si kadın, 25'i erkekti. Otuz hastada sadece büyüme hormonu boyanması varken kalan 37 hastada plurihormonal boyanma saptandı. Tiroid uyarıcı hormon (TSH) boyanması olan 14 hastanın üçüne preoperatif olarak TSH salgılayan hipofiz adenomları tanısı konmuştu. Bu üç olgu dışında klinik ve laboratuvar olarak hormon sekrete eden adenom saptanmadı. Tartışma: Çalışmamız akromegali hastalarında immünohistokimyasal olarak saptanan boyanma paternleri ile klinik ve laboratuvar bulguları arasında ilişki olmadığını gösterdi.

🔖

Cite This Article

TUNA, M. M., KARAKILIÇ, E., BAŞARAN, M. N., AYÇİÇEK, B. D., IMGA, N. N., ARDUÇ, A., ÜNAL, T., TÜTÜNCÜ, Y., BERKER, D., GÜLER, S. (2016). Büyüme Hormonu Salgılayan Adenomlarda İmmünohistokimyasal İnceleme Sonuçları ile Laboratuvar Bulguları Arasındaki Korelasyon. Turkish Journal of Endocrinology and Metabolism, Cilt: 20 - Sayı: 3, 69–71. https://ajindex.com/articles/370810

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613-619.
  2. DeLellis RA, Lloyd RV, Heitz PU, Eng C, Pathology and genetics of tumours of endocri-ne organs, World Health Organization Classification of Tumours, IARC Press, Lyon, 2004.
  3. Schmid M, Münscher A, Saeger W, Schreiber S, Lüdecke DK. Pituitary hormone mRNA in null cell adenomas and oncocytomas by in situ hybridization comparison with immu-nohistochemical and clinical data. Pathol Res Pract 2001;197:663-669.
  4. Yamada S, Kovacs K, Horvath E, Aiba T. Morphological study of clinically nonsecreting pituitary adenomas in patients under 40 years of age. J Neurosurg 1991;75:902-905.
  5. Dumbrava M, Costinean S, Stancu C, Badiu C. "Mind the gap" in immunohistochemical techniques used in pathology of pituitary adenomas. Acta Endocrinol Buc 2005;1:411-422.
  6. Wang M, Mou C, Jiang M, Han L, Fan S, Huan C, Qu X, Han T, Qu Y, Xu G. The cha-racteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases. Eur J Endocrinol 2012;166:797-802.
  7. Balinişteanu B, Ceauşu RA, Cîmpean AM, Baciu I, Baculescu N, Coculescu M, Raica M Conventional examination versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases. Rom J Morphol Embryol 2011;52:1041-1045.
  8. Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB. Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 2005;90:3089-3099. Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology 2006;83:179-188.
  9. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohis-tological classification of pituitary tumors: 10 years of experience with the German Pitui-tary Tumor Registry. Eur J Endocrinol 2007;156:203-216.
  10. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Mönting J, Reincke M. Expres-sion of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velo-city and invasiveness. J Neurosurg 2003;99:674-679.
  11. Mori R, Inoshita N, Takahashi-Fujigasaki J, Joki T, Nishioka H, Abe T, Fujii T, Yamada S. Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokera-tin Distribution. ISRN Endocrinol. 2013; 2013:723432. Pawlikowski M, Kune